Serious Side Effects Although less common, some serious side effects may occur, including: Pancreatitis: Severe upper stomach pain that may spread to the back, often with nausea or vomiting
However, driven by shifts in dietary patterns and rising obesity rates, its incidence and prevalence are steadily increasing, with the disease increasingly manifesting in younger individuals ( Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a novel class of antidiabetic agents that activate the GLP-1 receptor to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner, delay gastric emptying, thereby controlling blood glucose and promoting weight loss ( Previous meta-analyses have primarily pooled the cardiovascular effects of GLP-1 RAs in patients with T2DM ( This study performed a systematic review and meta-analysis to evaluate the effects of subcutaneous vs
Treating obesity with behavior change, generic anti-obesity medications, and GLP-1 seems to reduce the risk profile associated with all of these [cardiometabolic] diseases, Frank added
A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction
Avoid excessive alcohol consumption as it may interfere with the absorption of vitamin B12
It targets melanocortin receptors in the brain to directly trigger the feeling of arousal and desire